vs

Side-by-side financial comparison of loanDepot, Inc. (LDI) and Privia Health Group, Inc. (PRVA). Click either name above to swap in a different company.

Privia Health Group, Inc. is the larger business by last-quarter revenue ($541.2M vs $310.3M, roughly 1.7× loanDepot, Inc.). Privia Health Group, Inc. runs the higher net margin — 1.7% vs -7.2%, a 8.9% gap on every dollar of revenue. On growth, loanDepot, Inc. posted the faster year-over-year revenue change (20.5% vs 17.4%). Over the past eight quarters, loanDepot, Inc.'s revenue compounded faster (18.0% CAGR vs 14.2%).

LoanDepot, sometimes stylized as loanDepot, is an Irvine, California-based nonbank holding company which sells mortgage and non-mortgage lending products.

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

LDI vs PRVA — Head-to-Head

Bigger by revenue
PRVA
PRVA
1.7× larger
PRVA
$541.2M
$310.3M
LDI
Growing faster (revenue YoY)
LDI
LDI
+3.1% gap
LDI
20.5%
17.4%
PRVA
Higher net margin
PRVA
PRVA
8.9% more per $
PRVA
1.7%
-7.2%
LDI
Faster 2-yr revenue CAGR
LDI
LDI
Annualised
LDI
18.0%
14.2%
PRVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LDI
LDI
PRVA
PRVA
Revenue
$310.3M
$541.2M
Net Profit
$-22.5M
$9.2M
Gross Margin
Operating Margin
-10.3%
2.1%
Net Margin
-7.2%
1.7%
Revenue YoY
20.5%
17.4%
Net Profit YoY
32.4%
108.0%
EPS (diluted)
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LDI
LDI
PRVA
PRVA
Q4 25
$310.3M
$541.2M
Q3 25
$323.3M
$580.4M
Q2 25
$282.5M
$521.2M
Q1 25
$273.6M
$480.1M
Q4 24
$257.5M
$460.9M
Q3 24
$314.6M
$437.9M
Q2 24
$265.4M
$422.3M
Q1 24
$222.8M
$415.2M
Net Profit
LDI
LDI
PRVA
PRVA
Q4 25
$-22.5M
$9.2M
Q3 25
$-4.9M
$6.9M
Q2 25
$-13.4M
$2.7M
Q1 25
$-21.9M
$4.2M
Q4 24
$-33.2M
$4.4M
Q3 24
$1.4M
$3.5M
Q2 24
$-32.2M
$3.5M
Q1 24
$-34.3M
$3.0M
Operating Margin
LDI
LDI
PRVA
PRVA
Q4 25
-10.3%
2.1%
Q3 25
-3.2%
2.5%
Q2 25
-11.4%
0.6%
Q1 25
-16.8%
1.1%
Q4 24
-32.7%
1.1%
Q3 24
1.1%
1.3%
Q2 24
-29.1%
1.2%
Q1 24
-38.2%
0.2%
Net Margin
LDI
LDI
PRVA
PRVA
Q4 25
-7.2%
1.7%
Q3 25
-1.5%
1.2%
Q2 25
-4.7%
0.5%
Q1 25
-8.0%
0.9%
Q4 24
-12.9%
1.0%
Q3 24
0.4%
0.8%
Q2 24
-12.1%
0.8%
Q1 24
-15.4%
0.7%
EPS (diluted)
LDI
LDI
PRVA
PRVA
Q4 25
$0.08
Q3 25
$0.05
Q2 25
$0.02
Q1 25
$0.03
Q4 24
$0.03
Q3 24
$0.01
$0.03
Q2 24
$-0.18
$0.03
Q1 24
$-0.19
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LDI
LDI
PRVA
PRVA
Cash + ST InvestmentsLiquidity on hand
$337.2M
$479.7M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$386.0M
$737.2M
Total Assets
$6.9B
$1.4B
Debt / EquityLower = less leverage
5.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LDI
LDI
PRVA
PRVA
Q4 25
$337.2M
$479.7M
Q3 25
$459.2M
$441.4M
Q2 25
$408.6M
$390.1M
Q1 25
$371.5M
$469.3M
Q4 24
$421.6M
$491.1M
Q3 24
$483.0M
$422.0M
Q2 24
$533.2M
$387.4M
Q1 24
$603.7M
$351.1M
Total Debt
LDI
LDI
PRVA
PRVA
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.3B
Stockholders' Equity
LDI
LDI
PRVA
PRVA
Q4 25
$386.0M
$737.2M
Q3 25
$433.3M
$709.1M
Q2 25
$439.1M
$682.9M
Q1 25
$469.3M
$659.4M
Q4 24
$506.6M
$635.2M
Q3 24
$592.0M
$614.9M
Q2 24
$578.9M
$595.4M
Q1 24
$637.3M
$576.8M
Total Assets
LDI
LDI
PRVA
PRVA
Q4 25
$6.9B
$1.4B
Q3 25
$6.2B
$1.4B
Q2 25
$6.2B
$1.3B
Q1 25
$6.4B
$1.2B
Q4 24
$6.3B
$1.1B
Q3 24
$6.4B
$1.1B
Q2 24
$5.9B
$1.1B
Q1 24
$6.2B
$1.0B
Debt / Equity
LDI
LDI
PRVA
PRVA
Q4 25
5.44×
Q3 25
4.83×
Q2 25
4.70×
Q1 25
4.30×
Q4 24
4.00×
Q3 24
3.31×
Q2 24
3.41×
Q1 24
3.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LDI
LDI
PRVA
PRVA
Operating Cash FlowLast quarter
$-638.7M
$127.5M
Free Cash FlowOCF − Capex
$-648.0M
FCF MarginFCF / Revenue
-208.9%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
13.93×
TTM Free Cash FlowTrailing 4 quarters
$-734.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LDI
LDI
PRVA
PRVA
Q4 25
$-638.7M
$127.5M
Q3 25
$43.4M
$52.0M
Q2 25
$67.6M
$8.0M
Q1 25
$-179.9M
$-24.1M
Q4 24
$47.7M
$74.8M
Q3 24
$-349.2M
$33.2M
Q2 24
$-278.3M
$34.5M
Q1 24
$-278.5M
$-33.1M
Free Cash Flow
LDI
LDI
PRVA
PRVA
Q4 25
$-648.0M
Q3 25
$38.7M
Q2 25
$61.4M
Q1 25
$-186.7M
Q4 24
$40.8M
Q3 24
$-356.4M
Q2 24
$-285.7M
Q1 24
$-283.3M
FCF Margin
LDI
LDI
PRVA
PRVA
Q4 25
-208.9%
Q3 25
12.0%
Q2 25
21.7%
Q1 25
-68.2%
Q4 24
15.8%
Q3 24
-113.3%
Q2 24
-107.7%
Q1 24
-127.2%
Capex Intensity
LDI
LDI
PRVA
PRVA
Q4 25
3.0%
Q3 25
1.5%
Q2 25
2.2%
Q1 25
2.5%
Q4 24
2.7%
Q3 24
2.3%
Q2 24
2.8%
Q1 24
2.1%
Cash Conversion
LDI
LDI
PRVA
PRVA
Q4 25
13.93×
Q3 25
7.58×
Q2 25
2.97×
Q1 25
-5.70×
Q4 24
17.00×
Q3 24
-255.05×
9.38×
Q2 24
9.94×
Q1 24
-11.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LDI
LDI

Segment breakdown not available.

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

Related Comparisons